TetraLogic Pharmaceuticals (TLOG)

Oncology Corporate Profile

Stock Performance

0.0490
-0.0010

HQ Location

343 Phoenixville Pike
Malvern, PA 19355

Company Description

TetraLogic Pharmaceuticals is a leader in the discovery and development of small molecule drugs called Smac mimetics for the treatment of cancers. Smac mimetics are an entirely new class of targeted drugs that specifically induce cancer cell death and inhibit fundamental mechanisms of cancer cell survival and resistance, enabling tumors to die. TetraLogic's lead Smac mimetic drug, birinapant, is in Phase 2 clinical trials and is being developed for both solid tumors and hematological malignancies as a single agent and in combination with several standard-of-care cancer therapies.

Website: http://www.tetralogicpharma.com/

This company does not have any commercial products
  • Brand
  • Generic
  • Investigational
Brand / Product Class Area of Study Phase Partnership
birinapantpeptidomimetic of SmacMyelodysplastic Syndrome (MDS)II
birinapantpeptidomimetic of SmacOvarian cancerII
birinapantpeptidomimetic of SmacColorectal cancerI
birinapantpeptidomimetic of SmacCutaneous T-cell Lymphoma (CTCL)I
TL32711peptidomimetic of SmacElderly patients with Acute Myelogenous Leukemia (AML)I
TL32711peptidomimetic of SmacVarious cancer typesI
TL32711 (+ chemotherapy)peptidomimetic of SmacVarious cancer typesI

View additional information on product candidates here »

Source


http://www.tetralogicpharma.com/

Recent News Headlines

TetraLogic Pharmaceuticals Corporation Announces Completion of Sale of SMAC Mimetic and HDAC Inhibitor Assets to Medivir AB

12/29/2016 03:03 pm

[GlobeNewswire] - PAOLI, Pa., Dec. 29, 2016-- TetraLogic Pharmaceuticals Corporation and its wholly-owned subsidiary TetraLogic Research and Development Corporation today announced that they have completed the sale to Medivir ...

TetraLogic Announces Agreements to Sell SMAC mimetic and HDAC inhibitor assets to Medivir and to Restructure its Convertible Senior Notes and Delisting of Common Stock

11/2/2016 10:00 pm

[at noodls] - TetraLogic Pharmaceuticals Corporation (NASDAQ: TLOG) ('TetraLogic' or 'Company'), a clinical-stage biopharmaceutical company focused on discovering and developing novel small molecule therapeutics in ...

Medivir strengthens its clinical pipeline by entering into agreement to acquire a portfolio of clinical stage oncology programs

11/2/2016 08:04 pm

[at noodls] - Press release as PDF Stockholm, Sweden - Medivir AB (Nasdaq Stockholm: MVIR)today announces that it has entered into an agreement to acquire two clinical stage oncology programs from Tetralogic Pharmaceuticals ...

TetraLogic Announces Agreements to Sell SMAC mimetic and HDAC inhibitor assets to Medivir and to Restructure its Convertible Senior Notes and Delisting of Common Stock

11/2/2016 08:03 pm

[GlobeNewswire] - PAOLI, Pa., Nov. 02, 2016-- TetraLogic Pharmaceuticals Corporation, a clinical-stage biopharmaceutical company focused on discovering and developing novel small molecule therapeutics in oncology and infectious ...

4 Trending Small Cap Stocks That You Need To Watch Today

4/26/2016 12:02 pm

[Accesswire] - NEW YORK, NY / ACCESSWIRE / April 26, 2016 / The OTC Expert is issuing a report on four stocks that are trading with heavier than usual volume. LPTN , TLOG , HTM and VSTM are on high volume watch. Continue ...

Penny Stocks To Watch: Four Top Small Cap Stocks on Monday April 25

4/25/2016 04:04 pm

[Accesswire] - MIAMI, FL / ACCESSWIRE / April 25, 2016 / Daily Stock Reporter is issuing a report on four stocks to watch. TLOG, LPTN, OREX, and BTUUQ have been added to our watch list today. Continue reading to find ...

Top Penny Stocks: Four Small Cap Stocks You Should Be Watching On April 15th

4/15/2016 04:00 pm

[Accesswire] - MIAMI, FL / ACCESSWIRE / April 15, 2016 / Daily Stock Reporter is issuing a report on four stocks to watch. EBIO , EXXI, TLOG, and RMHB have been added to our watch list today. Continue reading to find ...